Atrinsic Inc. (NASDAQ:PTIX – Get Free Report) shares dropped 11.6% during mid-day trading on Tuesday . The stock traded as low as $0.4323 and last traded at $0.5460. Approximately 6,421 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 38,703 shares. The stock had previously closed at $0.6175.
Atrinsic Stock Down 11.6%
The company has a 50 day simple moving average of $0.64 and a 200-day simple moving average of $0.90. The stock has a market capitalization of $988,260.00, a price-to-earnings ratio of -0.07 and a beta of 1.13.
About Atrinsic
Protagenic Therapeutics, Inc, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc is headquartered in New York, New York.
Further Reading
- Five stocks we like better than Atrinsic
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for Atrinsic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrinsic and related companies with MarketBeat.com's FREE daily email newsletter.
